Cancer Center Support Grant

癌症中心支持补助金

• 批准号: 7235402
• 负责人: MARY C. BECKERLE
• 金额: $ 69.35万
• 依托单位: UNIVERSITY OF UTAH
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-05-09 至 2010-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7235402
• 关键词: Ambulatory Care Facilities; Area; Cancer Center Support Grant; Cancer Control; Clinical Research; Clinical Trials; Coordination and Collaboration; Disorder by Site; Facility Construction Funding Category; Fostering; Funding; Growth; Hospitals; Institutes; Interdisciplinary Study; Laboratories; Latino; Lead; Leadership; Learning; Malignant Childhood Neoplasm; Malignant Neoplasms; Malignant neoplasm of ovary; Medical Oncologist; Native Americans; Operative Surgical Procedures; Peer Review; Phase I Clinical Trials; Population Sciences; Positioning Attribute; Productivity; Publications; Radiation; Radiation Oncology; Recruitment Activity; Reporting; Research; Research Personnel; Research Support; Resource Sharing; Rural; Series; Structure; Training; Translational Research; Underserved Population; Universities; anticancer research; design; member; neurosurgery; outreach; programs; Ambulatory Care Facilities; Area; Cancer Center Support Grant; Cancer Control; Clinical Research; Clinical Trials; Coordination and Collaboration; Disorder by Site; Facility Construction Funding Category; Fostering; Funding; Growth; Hospitals; Institutes; Interdisciplinary Study; Laboratories; Latino; Lead; Leadership; Learning; Malignant Childhood Neoplasm; Malignant Neoplasms; Malignant neoplasm of ovary; Medical Oncologist; Native Americans; Operative Surgical Procedures; Peer Review; Phase I Clinical Trials; Population Sciences; Positioning Attribute; Productivity; Publications; Radiation; Radiation Oncology; Recruitment Activity; Reporting; Research; Research Personnel; Research Support; Resource Sharing; Rural; Series; Structure; Training; Translational Research; Underserved Population; Universities; anticancer research; design; member; neurosurgery; outreach; programs

Huntsman Cancer Institute has been an NCI-designated center since 1986. In this application for competitive renewal, we also are seeking designation as a Comprehensive Center. Since the last review, we have made substantial progress: we created programs in Pediatric Cancers, Ovarian Cancer, and Cancer Control and Population Sciences; we added 42 new members from external recruitment including 20 oncologists-- medical, surgical, dermatological, and radiation; we recruited new Chairs of Surgery, Neurosurgery, and Radiation Oncology--all of whom have leadership positions in the Center; we recruited two senior medical oncologists to lead our clinical trials programs; we conducted four investigator-initiated Phase 1 trials; and we initiated an outreach effort across our vast geographical area, with special emphasis on underserved populations in this region--Native Americans, rural residents, and Latinos. In addition, we sharpened the cancer focus of our research programs, which maintain a high level of productivity. Interdisciplinary research interactions are fostered by center- and program-sponsored activities including a seminar series, retreats, and training initiatives, as well as outstanding shared resources. Nearly 30% of our peer-reviewed publications since 1998 reflect inter-programmatic efforts, illustrating a high degree of interdisciplinary coordination and collaboration. In the past funding period, we completed construction on a 230,000 ft(2) building that contains laboratories, offices, an outpatient clinic, clinical research support, and a Cancer Learning Center. We also designed and began construction on a 330,000 ft(2) cancer research hospital (opening in 2004) that will be an extension of the current building. There has been outstanding institutional support for all aspects of our growth, including a new structure in which the Executive Director, Dr. Prescott, reports directly to the President of the University. We plan continued expansion over the next five years, with enduring emphasis on developing disease-site specific research programs to facilitate translational research.

亨斯曼癌症研究所（Huntsman Cancer Institute）自1986年以来一直是NCI指定的中心。在竞争性更新的申请中，我们还寻求名称为综合中心。自上次审查以来，我们取得了重大进展：我们在小儿癌，卵巢癌以及癌症控制和人群科学方面创建了计划；我们增加了来自外部招聘的42名新成员，其中包括20位肿瘤学家 - 医学，外科，皮肤病学和辐射；我们招募了新的外科手术，神经外科和放射肿瘤学的椅子 - 所有这些人都在中心担任领导职务；我们招募了两名高级医学肿瘤学家来领导我们的临床试验计划；我们进行了四个研究者发动的第1期试验；我们在广阔的地理区域开始了宣传工作，特别强调了服务不足的 该地区的人口 - 本地的美国人，农村居民和拉丁裔。 此外，我们提高了研究计划的癌症重点，这些癌症保持了高水平的生产率。跨学科的研究互动是由中心和计划赞助的活动促进的，包括研讨会系列，撤退和培训计划以及出色的共享资源。自1998年以来，我们将近30％的同行评审出版物反映了典型的努力，这说明了高度的跨学科协调和协作。 在过去的资金期间，我们完成了一座拥有实验室，办公室，门诊诊所，临床研究支持和癌症学习中心的230,000英尺（2）座建筑的建设。我们还设计并开始在330,000英尺（2）个癌症研究医院（2004年开业）上建造，这将是当前建筑物的延伸。对我们增长的各个方面的机构提供了杰出的支持，其中包括一种新结构，执行董事普雷斯科特博士直接向大学校长报告。我们计划在未来五年内持续扩展，并持续着重于制定特定疾病的研究计划以促进转化研究。